Results 191 to 200 of about 2,555,643 (332)
Innovative cryogenic cooling material using spin frustration from abundant elements. [PDF]
Terada N +3 more
europepmc +1 more source
The miscut substrate strategy offers a novel means to engineer aluminum surface roughness, grain architecture, crystallinity, and both normal and superconducting transport properties toward their clean limits by precisely tuning the miscut angle without altering growth conditions.
Thi‐Hien Do +13 more
wiley +1 more source
Quantum refrigeration powered by noise in a superconducting circuit. [PDF]
Sundelin S +4 more
europepmc +1 more source
XAHRM‐Lab First Results and πXRF First View of UFe4Al8 and UFe10Si2
ABSTRACT Following the installation of the Laboratory for the Characterization and Speciation of Aerosols (LCEA) in 2008, and the confirmation of High Resolution Energy Dispersive Spectrometry (HiREDS) as a much promising development for X‐ray Emission Spectrometry in general and Particle Induced X‐ray Emission (PIXE) in particular, the installation of
M. A. Reis +3 more
wiley +1 more source
Reduced hysteresis in La<sub>0.7</sub>Ce<sub>0.3</sub>Fe<sub>11.5</sub>Si<sub>1.5</sub> hydrides by grain size reduction. [PDF]
Prusty MM +5 more
europepmc +1 more source
Palaeoenvironmental records along the eastern coast of Thailand remain sparse, with only a few studies attempting to reconstruct past climatic and environmental conditions. However, additional palaeoenvironmental, palaeoclimatic and sea‐level records are needed to improve our understanding of coastal evolution and local environmental changes.
Sakonvan Chawchai +7 more
wiley +1 more source
Regulation of magnetocaloric properties and critical behavior of La<sub>0.7</sub>Sr<sub>0.3</sub>MnO<sub>3</sub> by high-pressure heat treatment. [PDF]
Jin X +6 more
europepmc +1 more source
The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui +11 more
wiley +1 more source
Highly ordered rubbers with a giant elastocaloric effect. [PDF]
Fu Y +14 more
europepmc +1 more source
0406 Regenerative Magnetic Refrigerator Using Magnetic Suspension
Masahiro NOMURA +2 more
openaire +2 more sources

